Eugenol /OVA is an antigen-adjuvant conjugate formed by the conjugation of Eugenol with Ovalbumin (OVA). By conjugating the antigen with a protein adjuvant , the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt key epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.